Join
Live feed
·
INSIDERFilingvia Quantisnow
KalVista Pharmaceuticals Inc. logo

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 2,419 shares and sold $30,212 worth of shares (1,129 units at $26.76), increasing direct ownership by 0.28% to 467,665 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KALV (KalVista Pharmaceuticals Inc.) and more on Quantisnow.

CHIEF EXECUTIVE OFFICER Palleiko Benjamin L converted options into 2,419 shares and sold $30,212 worth of shares (1,129 units at $26.76), increasing direct ownership by 0.28% to 467,665 units (SEC Form 4) to cover withholding tax | Quantisnow